<DOC>
	<DOCNO>NCT01083745</DOCNO>
	<brief_summary>The etiology infertility majority patient poor response ovarian stimulation remain unknown . This study investigate role immune cell ( T cell , B cell , dendritic cell NK cell ) , constitute immune system normally fights infection cancer . We , investigator , find specialize NK cell help new blood vessel formation , find fluid surround egg IVF , patient good response ovarian stimulation . We wish expand study correlate finding ovarian blood flow , measure 3D ultrasound presence cell immune system .</brief_summary>
	<brief_title>Assessment Blood Follicular Fluid Immune Cell Constitution Patients Undergoing Vitro Fertilization</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Female</mesh_term>
	<criteria>Age 2743 year Diagnosis infertility due endometriosis , severe male factor , tubal occlusion . Patient undergo IVF Body mass index ( BMI ) &gt; 38 kg/m2 Abnormal uterine cavity evidence sonohysterogram hysterosalpingography Any current use systemic steroid medication infertility treatment within 3 month study enrollment . Any contraindication pregnant carry pregnancy term . Any ovarian abdominal abnormality may interfere adequate TVS evaluation . Absence one two ovary Clinically relevant systemic disease ( e.g. , Insulindependent diabetes , adrenal dysfunction , organic intracranial lesion , polycystic ovarian syndrome , hyperprolactinemia , hypothalamic tumor ) serious illness ( Neoplasia ) . History ( within past 12 month ) current abuse alcohol drug . Administration investigational drug within three month prior study enrollment . Any medical condition may interfere absorption , distribution , metabolism excretion study drug , gastrointestinal disease , mal absorption syndrome liver dysfunction Unexplained gynecological bleeding . Ejaculated sperm sufficient ICSI Patient able communicate adequately investigator comply requirement entire study . Abnormal COH screen blood do partner , include : prolactin , thyroid stimulate hormone , HIV serology , Hepatitis B C serology , Rubella , group screen syphilis serology prior participation study . Unwillingness give write informed consent . Previous entry study simultaneous participation another clinical trial .</criteria>
	<gender>Female</gender>
	<minimum_age>27 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>